RFLRafael Holdings, Inc. Class B Common Stock

CSNew York Stock Exchange (XNYS)·USD

Identity

Security key: 20930
Ticker: RFL
Type: CS — Common Stock
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 2018-03-06
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: RFL

Detail

Enriched 2026-08-14 20:47

Market cap: $102,959,992.08
Shares outstanding (class): 51,212,833
Shares outstanding (weighted): 51,999,996
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 23
Location: NEWARK, NJ
Homepage: https://www.rafaelholdings.com
Description: Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Market cap and share counts drift.

Funds holding this security

11 funds · 11 positions · $1.70M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$956.5K	0.00%	765,238 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$595.0K	0.00%	475,997 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$98.4K	0.01%	78,711 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$23.3K	0.00%	18,676 NS	FIGI
Small Cap Core Fund Northern Funds	—	$13.0K	0.00%	10,432 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$6.5K	0.00%	5,170 NS	FIGI
JNL/DFA U.S. Small Cap Fund JNL Series Trust	—	$5.2K	0.00%	4,149 NS	FIGI
LVIP Dimensional U.S. Core Equity 1 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$2.1K	0.00%	1,698 NS	FIGI
JNL/DFA U.S. Core Equity Fund JNL Series Trust	—	$1.7K	0.00%	1,390 NS	FIGI
AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust	—	$1.2K	0.00%	997 NS	FIGI
LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$1.1K	0.00%	887 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERRFL
FIGI_COMPOSITEBBG00J3YYS92
FIGI_SHARE_CLASSBBG00J3YYSB9
CIK0001713863
ISINUS75062E1064
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The company is classified under SIC 2834 (Pharmaceutical Preparations) and is a common stock, indicating equity exposure to the healthcare pharmaceuticals sector.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.